Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.

NCT00609492 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Streptococcal
Streptococcus Pneumoniae Vaccines

Interventions

BIOLOGICAL: GSK Biologicals´ Pneumococcal Conjugate Vaccine (GSK1024850A)
BIOLOGICAL: Infanrix™-IPV/Hib

Sponsor

GlaxoSmithKline